Active ingredientSuplatast TosilateCat. No. P-S134-001CAS 94055-76-2Family · Pharmaceutical analytical standards
Suplatast
An immunomodulator that curbs the activity of Th2 lymphocytes, key players in allergic reactions, developed in Japan and patented in 1985 against bronchial asthma; Japanese studies have also evaluated it for allergic rhinitis and atopic dermatitis. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Instead of blocking histamine it acts 'upstream': it reduces IgE production and allergy-related eosinophils. It has also been used in some cases of Kimura disease, a rare inflammatory condition.
Go to the active ingredient →Active ingredientSuplatast TosilateCat. No. P-S134-001CAS 94055-76-2
Isotopically labelledSuplatast Impurity 3-d5Cat. No. P-S134-002
Isotopically labelledSuplatast-d4 TosylateCat. No. P-S134-003
ImpurityMethyl 4-methylbenzenesulfonateCat. No. P-S134-005CAS 80-48-8
ImpuritySuplatast Impurity 1Cat. No. P-S134-007
ImpuritySuplatast Impurity 2Cat. No. P-S134-008
ImpuritySuplatast Impurity 3Cat. No. P-S134-009CAS 145133-19-3No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.